21-08-2023
Kedrion Biopharma Supports the Rare Disease Community at the 75th Annual Bleeding Disorders Conference
Read all
Kedrion supported the Plasminogen Deficiency Foundation in a roundtable for patients with Congenital Plasminogen Deficiency.
25-07-2023
Kedrion Biopharma Announces Support for the Immune Deficiency Foundation Research Grant Program for Second Consecutive Year
Read all
The IDF Research Grant Program is designed to encourage and support patient-oriented research on primary immunodeficiencies (PI),
19-07-2023
Kedrion confirms its commitment against Rabies infections in the US
Read all
Distribution agreement with Kamada for KEDRAB® extended until March 2026